Literature DB >> 21293126

Splenectomy in chronic hepatic disorders: portal vein thrombosis and improvement of liver function.

Yuichiro Ushitora1, Hirotaka Tashiro, Shoichi Takahashi, Hironobu Amano, Akihiko Oshita, Tsuyoshi Kobayashi, Kazuaki Chayama, Hideki Ohdan.   

Abstract

BACKGROUND: Splenectomy is gaining increasing importance for cirrhotic patients with hypersplenism. However, its safety and efficacy for patients with chronic liver disease remain unclear.
METHODS: We retrospectively examined the medical records of 38 consecutive cirrhotic patients who underwent splenectomy or simultaneous hepatectomy and splenectomy for hepatocellular carcinoma.
RESULTS: White blood cell and platelet counts significantly increased 3 months after splenectomy. Serum levels of total bilirubin and prothrombin time significantly improved 1 year after splenectomy. Interferon therapy was administered to 25 patients after splenectomy. A sustained viral response was achieved in 8 patients (42%). The total incidence of portal or splenic vein thrombosis (PSVT) detected by postoperative dynamic computed tomography was 13/38 (34.2%). Multivariate analysis revealed preoperative spleen volume (SV) to be the sole independent predictor of postoperative PSVT. Receiver-operator characteristic curve analysis showed that a cut-off SV of 450 ml corresponded to a sensitivity of 85% and a specificity of 56%.
CONCLUSIONS: Splenectomy improved the liver function and facilitated effective interferon therapy in cirrhotic patients with hypersplenism, although preoperative SV was frequently associated with postoperative PSVT.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21293126     DOI: 10.1159/000321886

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  28 in total

1.  Long-term postoperative outcomes of hypersplenism: laparoscopic versus open splenectomy secondary to liver cirrhosis.

Authors:  Jin Zhou; Zhong Wu; Prasoon Pankaj; Bing Peng
Journal:  Surg Endosc       Date:  2012-05-31       Impact factor: 4.584

2.  Anticoagulation therapy prevents portal-splenic vein thrombosis after splenectomy with gastroesophageal devascularization.

Authors:  Wei Lai; Shi-Chun Lu; Guan-Yin Li; Chuan-Yun Li; Ju-Shan Wu; Qing-Liang Guo; Meng-Long Wang; Ning Li
Journal:  World J Gastroenterol       Date:  2012-07-14       Impact factor: 5.742

3.  Impact of Splenic Volume and Splenectomy on Prognosis of Hepatocellular Carcinoma Within Milan Criteria After Curative Hepatectomy.

Authors:  Kazuki Takeishi; Hirofumi Kawanaka; Shinji Itoh; Norifumi Harimoto; Toru Ikegami; Tomoharu Yoshizumi; Ken Shirabe; Yoshihiko Maehara
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

4.  Packaging functionally important plasma proteins into the α-granules of human-induced pluripotent stem cell-derived megakaryocytes.

Authors:  Nanyan Zhang; Peter J Newman
Journal:  J Tissue Eng Regen Med       Date:  2019-01-04       Impact factor: 3.963

5.  Adverse factors responsible for below-normal platelet count after laparoscopic splenectomy and azygoportal disconnection.

Authors:  Dou-Sheng Bai; Wen-Yu Shao; Chi Zhang; Ping Chen; Sheng-Jie Jin; Guo-Qing Jiang
Journal:  Turk J Gastroenterol       Date:  2019-03       Impact factor: 1.852

6.  Splanchnic Vein Thrombosis in Liver Cirrhosis After Splenectomy or Splenic Artery Embolization: A Systematic Review and Meta-Analysis.

Authors:  Yanyan Wu; Hongyu Li; Tiansong Zhang; Zhaohui Bai; Xiangbo Xu; Giovanni Battista Levi Sandri; Le Wang; Xingshun Qi
Journal:  Adv Ther       Date:  2021-03-09       Impact factor: 3.845

7.  Hepatectomy combined with microwave ablation of the spleen for treatment of hepatocellular carcinoma complicated with splenomegaly: A retrospective study.

Authors:  Jian-Bo Han; Feng-Wei Kong; Hai Ding; Yu-Feng Zhang; Jun-Mao Liu; Qiang Wei; Liang Hu; Liang Zhao; Chuan-Jun Xu; Yong-Xiang Yi
Journal:  Mol Clin Oncol       Date:  2016-12-14

8.  Clinical effects of cluster technology optimization and innovations on laparoscopic splenectomy and azygoportal disconnection: a single-center retrospective study with 500 consecutive cases.

Authors:  Long-Fei Wu; Dou-Sheng Bai; Rong-Hua Gong; Sheng-Jie Jin; Chi Zhang; Bao-Huan Zhou; Jian-Jun Qian; Guo-Qing Jiang
Journal:  Surg Endosc       Date:  2022-03-07       Impact factor: 3.453

Review 9.  Management of thrombocytopenia in advanced liver disease.

Authors:  V G R Gangireddy; P C Kanneganti; S Sridhar; S Talla; T Coleman
Journal:  Can J Gastroenterol Hepatol       Date:  2014-09-15

10.  Effect of antiviral therapy on the survival and incidence of major complications in HBV-associated cirrhotic patients after splenectomy for hypersplenism and portal hypertension.

Authors:  Ningqiang Tian; Zhengwen Liu; Mingbo Yang; Zhu Li; Guoyu Zhang; Qunying Han; Na Li; Qianqian Zhu; Yi Lv; Yawen Wang; Fanfan Xing
Journal:  Virol J       Date:  2012-11-16       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.